Matches in Wikidata for { <http://www.wikidata.org/entity/Q80406284> ?p ?o ?g. }
Showing items 1 to 72 of
72
with 100 items per page.
- Q80406284 description "article scientifique publié en 2007" @default.
- Q80406284 description "artículu científicu espublizáu en xunu de 2007" @default.
- Q80406284 description "scientific article published on 01 June 2007" @default.
- Q80406284 description "wetenschappelijk artikel" @default.
- Q80406284 description "наукова стаття, опублікована в червні 2007" @default.
- Q80406284 name "Phase I/II trial of erlotinib and cisplatin in patients with recurrent or metastatic squamous cell carcinoma of the head and neck: a Princess Margaret Hospital phase II consortium and National Cancer Institute of Canada Clinical Trials Group Study" @default.
- Q80406284 name "Phase I/II trial of erlotinib and cisplatin in patients with recurrent or metastatic squamous cell carcinoma of the head and neck: a Princess Margaret Hospital phase II consortium and National Cancer Institute of Canada Clinical Trials Group Study" @default.
- Q80406284 type Item @default.
- Q80406284 label "Phase I/II trial of erlotinib and cisplatin in patients with recurrent or metastatic squamous cell carcinoma of the head and neck: a Princess Margaret Hospital phase II consortium and National Cancer Institute of Canada Clinical Trials Group Study" @default.
- Q80406284 label "Phase I/II trial of erlotinib and cisplatin in patients with recurrent or metastatic squamous cell carcinoma of the head and neck: a Princess Margaret Hospital phase II consortium and National Cancer Institute of Canada Clinical Trials Group Study" @default.
- Q80406284 prefLabel "Phase I/II trial of erlotinib and cisplatin in patients with recurrent or metastatic squamous cell carcinoma of the head and neck: a Princess Margaret Hospital phase II consortium and National Cancer Institute of Canada Clinical Trials Group Study" @default.
- Q80406284 prefLabel "Phase I/II trial of erlotinib and cisplatin in patients with recurrent or metastatic squamous cell carcinoma of the head and neck: a Princess Margaret Hospital phase II consortium and National Cancer Institute of Canada Clinical Trials Group Study" @default.
- Q80406284 P1433 Q80406284-EE72629D-CE5E-42E1-A424-8E9E721352E1 @default.
- Q80406284 P1476 Q80406284-A22328BF-B580-4B50-8B7B-6A0B4B95C38D @default.
- Q80406284 P2093 Q80406284-0AEBEEEA-3766-4212-BB71-2887B1996F95 @default.
- Q80406284 P2093 Q80406284-13295D11-C3B0-49FB-B140-B4C1B4F76F19 @default.
- Q80406284 P2093 Q80406284-40117329-846D-4563-B26C-F9E64B3D07FF @default.
- Q80406284 P2093 Q80406284-4CD88723-61DD-48D5-AE27-D7EDFC63E711 @default.
- Q80406284 P2093 Q80406284-5511A476-6211-49CF-B9A9-36F8E41D17F7 @default.
- Q80406284 P2093 Q80406284-62F330AD-56BE-4AE5-8103-53FBCBA4DC01 @default.
- Q80406284 P2093 Q80406284-64F57DA1-401C-4B74-AEFC-879783E87531 @default.
- Q80406284 P2093 Q80406284-6A815B3F-52A0-4B1E-9B8D-6C974B8A8D6A @default.
- Q80406284 P2093 Q80406284-746B526E-AF0F-4CA1-8D64-AD43E12CEC86 @default.
- Q80406284 P2093 Q80406284-82258611-479F-475A-93C3-8F8C12139D01 @default.
- Q80406284 P2093 Q80406284-9D568B87-7240-496A-8C31-0B358FB88AF6 @default.
- Q80406284 P2093 Q80406284-A892A0ED-FB66-4C14-A12B-BA4C102D521A @default.
- Q80406284 P2093 Q80406284-B0D9A8F0-8714-413E-A7A8-C2FEB684D11C @default.
- Q80406284 P2093 Q80406284-D4E58297-591C-4E86-992C-E9FE59A03252 @default.
- Q80406284 P304 Q80406284-912DE028-B57B-4744-BE11-247041160692 @default.
- Q80406284 P31 Q80406284-E5E39613-6CA2-4F9C-B339-6DA95C60BEAF @default.
- Q80406284 P356 Q80406284-1303CA52-C171-4033-8543-AF4F72CC8813 @default.
- Q80406284 P433 Q80406284-C526E484-A147-465A-9747-EDAD1E38A20A @default.
- Q80406284 P478 Q80406284-EA9A9C7A-24C1-4398-9926-7FBE0FDC7348 @default.
- Q80406284 P577 Q80406284-6C2D6370-023B-4ADF-BB92-09224C419553 @default.
- Q80406284 P698 Q80406284-AEDC3F59-F023-44EC-89D5-EDA952507807 @default.
- Q80406284 P921 Q80406284-4A11451D-60B1-425E-9380-81C12758FAFF @default.
- Q80406284 P921 Q80406284-8C686B16-57DE-4CE1-9A0C-B24EA3B8CCA8 @default.
- Q80406284 P921 Q80406284-A1964074-4A03-4B27-99AB-88AC8A1D9D8D @default.
- Q80406284 P921 Q80406284-A214AC50-7F5F-4E2C-A56C-745E787ADA60 @default.
- Q80406284 P921 Q80406284-B570DEB3-9D8C-4651-9ADD-A211516BCF74 @default.
- Q80406284 P921 Q80406284-ED7F4467-79CD-4826-8757-530FE14A809A @default.
- Q80406284 P356 JCO.2006.07.6547 @default.
- Q80406284 P698 17538162 @default.
- Q80406284 P1433 Q400292 @default.
- Q80406284 P1476 "Phase I/II trial of erlotinib and cisplatin in patients with recurrent or metastatic squamous cell carcinoma of the head and neck: a Princess Margaret Hospital phase II consortium and National Cancer Institute of Canada Clinical Trials Group Study" @default.
- Q80406284 P2093 "Denis Soulieres" @default.
- Q80406284 P2093 "Elizabeth A Eisenhauer" @default.
- Q80406284 P2093 "Eric Winquist" @default.
- Q80406284 P2093 "Eric X Chen" @default.
- Q80406284 P2093 "Gregory R Pond" @default.
- Q80406284 P2093 "Janet Dancey" @default.
- Q80406284 P2093 "Lillian L Siu" @default.
- Q80406284 P2093 "Luc Harvey" @default.
- Q80406284 P2093 "Meri Klein" @default.
- Q80406284 P2093 "National Cancer Institute of Canada Clinical Trials Group Study" @default.
- Q80406284 P2093 "Peggy Francis" @default.
- Q80406284 P2093 "Princess Margaret Hospital Phase II Consortium" @default.
- Q80406284 P2093 "Soo F Chin" @default.
- Q80406284 P2093 "Wenjiang Zhang" @default.
- Q80406284 P304 "2178-2183" @default.
- Q80406284 P31 Q13442814 @default.
- Q80406284 P356 "10.1200/JCO.2006.07.6547" @default.
- Q80406284 P433 "16" @default.
- Q80406284 P478 "25" @default.
- Q80406284 P577 "2007-06-01T00:00:00Z" @default.
- Q80406284 P698 "17538162" @default.
- Q80406284 P921 Q16 @default.
- Q80406284 P921 Q18348812 @default.
- Q80406284 P921 Q18975728 @default.
- Q80406284 P921 Q412415 @default.
- Q80406284 P921 Q42824440 @default.
- Q80406284 P921 Q5452194 @default.